Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
Recap by typeshit. Post by Regen on X.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
He points to a November 2026 study he says suggests semaglutide and other GLP-1 drugs may help beyond diabetes and obesity in people with schizophrenia.
A short social post frames the semaglutide molecule as the start of a bigger business story for drugmakers, with a note that it is not medical advice.
Portela calls out people taking advice from TikTok comments to self-inject powders labeled not for human consumption, with melanotan as the example.
Loading…